Short answer
LifeMD, Inc. (LFMD) filed an 8-K current report with the SEC on May 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q1 2026 results announcement for the three months ended March 31, 2026.
LifeMD, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results announcement for the three months ended March 31, 2026
- Press release furnished as Exhibit 99.1, containing the financial details investors need
- Results disclosure may affect valuation and expectations for LifeMD common and preferred shares
Item 7.01 · Regulation FD Disclosure
- Investor presentation furnished as Exhibit 99.2 for meetings beginning May 6, 2026
- Presentation may be modified and should be evaluated alongside SEC filings and other public announcements
- Forward-looking content includes industry growth, company growth rates, and future cash flow expectations
- Investor take-away: guidance remains subject to material risks and no obligation to update projections
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LifeMD, Inc. 8-K filings
Get the next LFMD 8-K as it lands
Follow LFMD for push alerts, or ask the research agent what this filing means.